Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancer. [PDF]
Shao IH +11 more
europepmc +1 more source
Comparison of MRI artificial intelligence-guided cognitive fusion-targeted biopsy versus routine cognitive fusion-targeted prostate biopsy in prostate cancer diagnosis: a randomized controlled trial. [PDF]
Deng R +15 more
europepmc +1 more source
Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial. [PDF]
Niu S +12 more
europepmc +1 more source
The first-in-human preclinical evaluation of the new probe [123I]I-PSMA-7 for real-time intraoperative targeted biopsy and SPECT/CT imaging in prostate cancer. [PDF]
Luan X +15 more
europepmc +1 more source
Related searches:
Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores
Urologic Oncology: Seminars and Original Investigations, 2021Paul T Gellhaus +2 more
exaly
Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI
Clinical Genitourinary Cancer, 2023Michele Pennisi
exaly
MRI-Targeted, Systematic, or Combined Biopsy for Detecting Clinically Significant Prostate Cancer
Journal of the American College of Radiology, 2023Alexander P Cole +2 more
exaly
Magnetic Resonance Imaging Follow-up of Targeted Biopsy–negative Prostate Lesions
European Urology Focus, 2023Clare Allen +2 more
exaly

